Executive Director, Clinical Development

Alnylam Pharmaceuticals, Inc. Cambridge , MA 02138

Posted 2 months ago

Senior/Executive Director, CNS Clinical Development


Alnylam was founded in 2002 on a revolutionary vision and bold mission which remain firmly in place today. We are leading the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to transform the lives of people with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system diseases with unmet need. Our first medicine, the first-ever RNAi therapeutic, has recently been approved by the FDA in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults and by the European Medicines Agency in the EU for the treatment of hATTR amyloidosis in adults with stage 1 or stage 2 polyneuropathy. In addition, Alnylam has four investigational medicines in late-stage development. www.alnylam.com. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work in 2015, 2016, 2017 and 2018- four years in a row!

The Senior/Executive Director, CNS Clinical Development reports to the Chief Medical Officer and will be responsible for overseeing the successful development of multiple molecules in the Alnylam pipeline, with a focus on RNAi therapeutics for CNS and ocular diseases. Alnylam's existing clinical pipeline is comprised of liver-directed therapies that are being developed for a variety of diseases, which have been fueled by optimized approaches to hepatic delivery of small-interfering RNAs. However, more recent breakthroughs in delivery technology have created the opportunity to use RNAi therapeutics to treat a host of devastating CNS and ocular diseases, as well.

The Senior/Executive Director, CNS Clinical Development will be responsible for working closely with colleagues across Research and Development to inform target and indication selection, and to shape clinical-regulatory strategies to efficiently advance these molecules into and through clinical development. In this role, he/she will interface extensively with research colleagues and external experts to conduct collaborative research efforts, obtain feedback on clinical development plans, and stay abreast of new developments in the field. As molecules advance into the clinic, he/she will work with clinical development colleagues to oversee the design and timely progression of associated clinical trials. In addition to work on CNS assets, the successful candidate may also have responsibilities for the development of other assets in the Alnylam development portfolio across therapeutic areas, commensurate with their experience and interests.

The ideal candidate that we seek will be a highly innovative, collaborative, scientifically-grounded and accomplished Clinical Development physician with a flexible, hands-on and team-oriented style. The Senior/Executive Director, CNS Clinical Development will have matrix team leadership responsibilities, be a critical partner to counterparts in Research, Early Development, Regulatory, Clinical Operations, Data Sciences & Statistics, Safety and other expertise areas, and will have the opportunity to build and lead a team of clinical development physicians and clinical scientists. He/she will be a key Alnylam Development spokesperson at external meetings, including regulatory interactions and scientific meetings.

As a senior member of the Clinical Development organization, the Senior/Executive Director, CNS Clinical Development also will partner with the CMO and others to help build and lead a world-class, development organization as Alnylam grows toward realizing its vision of becoming a global, fully integrated, multi-product, biopharmaceutical company.

Summary of Key Responsibilities

  • Be a strategic clinical leader responsible for shaping creative and efficient clinical development strategies for multiple pipeline assets

  • Collaborate with Research and Early Development to identify drug targets and disease indications, and shape clinical development plans

  • Lead one or more clinical development teams, initially via matrix leadership, and ultimately via direct management of other MDs and clinical scientists

  • Play a leadership role in regulatory interactions to advance molecules through development and secure global regulatory approvals

  • Collaborate closely with Early Development, Regulatory, Clinical Operations, Data Sciences & Statistics, Medical Affairs and Commercial to ensure tight strategic integration of product development plans

  • Be accountable via Clinical Research and Operations for all relevant timelines and deliverables

  • Supervise closely all major written deliverables (regulatory submissions, original articles, abstracts), and presentation materials

  • Influence internal and external audiences in a high impact, highly visible fashion

  • Work with the Clinical Development Leadership Team to build and grow a highly effective development organization


  • A highly driven, dynamic, engaged and accomplished Clinical Development physician with solid drug development & leadership experience will thrive in this role. The successful candidate will be able to think on their feet, build strong working relationships and have an entrepreneurial spirit. Specific qualifications include:

  • MD with a strong research background or MD, PhD; specialty training in Neurology preferred. Experience in Genetics and/or Rare Diseases is desirable

  • Minimum 5-10 years of Clinical Development experience required. Previous experience in CNS drug development is highly preferred.

  • Experience leading clinical development programs, and actively participating in regulatory interactions with global health authorities; prior NDA/BLA/MAA preferred but not required.

  • Current working knowledge of legal, regulatory, and compliance regulations and guidelines; familiarity with concepts of clinical trial design, execution and statistics

  • Adaptable and able to effectively lead, collaborate and influence across a complex matrix organization.

  • Demonstrated leadership in ambiguous situations; able to inspire a team to excel by fostering a climate of energy, excitement and personal accountability.

  • Excellent written and verbal communication skills

  • Excited to work in a highly entrepreneurial biotech environment and embraces Alnylam's culture of science, passion and urgency.

Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment.

  • We are not accepting search firm or agency inquiries for this opportunity


icon no score

See how you match
to the job

Find your dream job anywhere
with the LiveCareer app.
Mobile App Icon
Download the
LiveCareer app and find
your dream job anywhere
App Store Icon Google Play Icon

Boost your job search productivity with our
free Chrome Extension!

lc_apply_tool GET EXTENSION

Similar Jobs

Want to see jobs matched to your resume? Upload One Now! Remove
Director Clinician Early Clinical Development (NonMd)


Posted 2 weeks ago

VIEW JOBS 4/5/2019 12:00:00 AM 2019-07-04T00:00 The overall role of the Early Clinical Development (ECD) Clinician is to lead and coordinate the development of multiple studies for novel biological and small molecule therapies for first in man (FIH), proof of mechanism (POM), early signals of efficacy (ESOE) and proof of concept (POC) studies in a given therapeutic areas: e.g., Internal Medicine, Immunology and Inflammation, and Rare Diseases. The ECD Clinician will participate as an individual contributor on clinical teams with Pfizer development operations to meet enrollment and study delivery timelines. The ECD Clinician will work with other functional disciples as needed (e.g. Research Units, Biostatistics, Clinical Pharmacology, Precision Medicine, and Digital Medicine). The individual will be involved with clinical drug development activities from FIH through POC. They will be a key member of clinical subteams to ensure collaboration and seamless connectivity between ECD, Research Units and Global Product Development. * Responsible for execution of clinical studies and delivering on innovative clinical study designs, safety assessment and interpretation of clinical study results * Supports execution for all post-FIH programs through proof-of concept * Serve as technical resource for clinical issues raised by internal and external collaborators, investigators, consultants and contractors * Support and assist in the development of publications, abstracts, and presentations * Sit on clinical subteams from FIH/POM/ESoE through POC trial completion to support clinical development implementation and contribution to key development milestones, e.g. start-up and delivery of ESoE and PoC trials. * Support preparation of critical documents, including but not limited to clinical protocol, clinical development plan, investigator brochure, clinical study report, and regulatory documents. * Collaborate between the clinical team and ECD by maintaining open communications between the two groups and ensuring successful program completion. * Foster a transparent environment that encourages strong partnerships and mutual trust between teams, sub-teams, and therapeutic areas. * Coordinate with other clinical research activities in ECD and greater World-Wide Research and Development (WRD) organization. * Develop effective collaborations with key partners in Pfizer Discovery Research Units (RU) as well as Centers for Therapeutic Innovation (CTI) and Precision Medicine. * Develop effective collaborations with project leaders and projects team members, including research units, biostatistics, regulatory affairs, clinical pharmacology, human genetics, precision medicine and development operations. * Partner with Precision Medicine as needed to ensure that biomarker plans are enabled in all relevant therapeutic area programs to help determine early signs of efficacy and proof of concept, patient stratification, etc. * Establish and support relationships with external experts, consultants, key opinion leaders, regulators and disease specific investigator networks to ensure implementation of latest clinical thinking and guidelines into clinical development plans and study designs, as well as management and recruitment of study, analysis, interpretation and presentation of results. * Maintain up-to-date knowledge of scientific and clinical published literature in relevant therapeutic areas including the key clinical development issues. Qualifications * Requires PhD, PharmD, MSc (relevant experience in Immunology, Cardiovascular/Metabololic, or Rare Disease preferred) * Deep understanding of the biopharmaceutical environment and the drug development * 5-8 years of relevant experience in drug development; 3-5 years of relevant experience in a clinician type role with a proven track record executing development programs to completion or targeted milestone * Strong interpersonal skills and team player with demonstrated ability to build consensus and thrive in a matrix team environment Technical Skills * A clear working knowledge of the clinical development process * Demonstrated ability to support the formulation and execution of clinical strategies; * Good understanding of relevant areas such as biostatistics, regulatory, clinical pharmacology, pre-clinical toxicology, pharmacogenomics and biomarker based approaches. * Ability to analyze and interpret complex datasets. * Ability to operate with a sense of pace and urgency in matrixed project teams. * Exercises initiative in meeting goals and drives innovation in projects. * Demonstrated scientific productivity (publications, abstracts, etc.). * Good communication and presentation skills as well as proven scientific writing skills. Core Competencies * Results-oriented with demonstrated track record of success in clinical development * Ability to navigate a complex matrixed environment and manage teams that are diverse in terms of expertise, background, and geography * Entrepreneurial mindset with the ability to bring creative solutions to challenges * Ability to think and frame problems strategically * Quick action taker, able to involve the right team members in the right situation at the right time with a fit for purpose attitude EEO & Employment Eligibility Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative. Other Job Details: * Eligible for Relocation Package * Eligible for Employee Referral Bonus Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates. Pfizer Cambridge MA

Executive Director, Clinical Development

Alnylam Pharmaceuticals, Inc.